Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1991-11-04
1993-10-05
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
424 851, 514 12, 514 21, 530380, 530402, 530816, 530829, A61K 3702, C07K 1506
Patent
active
052502953
ABSTRACT:
A factor (NKEF) for use in enhancing the activity of natural killer cells both in vivo and in vitro. NKEF is a soluble red blood cell cytosol protein having a molecular mass of between about 300 and 400 kilodaltons as determined by gel filtration high pressure liquid chromatography and an apparent molecular weight of about 48 kilodaltons as determined by non-reducing SDS-PAGE.
REFERENCES:
patent: 4883661 (1989-11-01), Daly et al.
patent: 5208218 (1993-05-01), Van Snick et al.
Shau, H. and Golub, S. "Modulation of Natural Killer-Mediated Lysis by Red Blood Cells", Cellular Immunology 116, 60-72, 1988.
Karger, S., "Abstract from Seventh International Workshop on Natural Killer Cells", Jun. 4-7, 1991, Stockholm, Sweden.
Iho, S., Shau, H. and Golub, S., "Characteristics of Interleukin-6-Enhanced Lymphokine-Activated Killer Cell Function", Cellular Immunology 135, 66-77 (1991).
Golub Sidney H.
Shau Hungyi
Russel Jeffrey E.
The Regents of the Univ. of California
LandOfFree
Natural killer cell enhancing factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Natural killer cell enhancing factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Natural killer cell enhancing factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1002196